Today’s spine market is dominated by late-stage reconstructive fusion — primarily performed by spine surgeons using traditional open techniques and conventional MISS. At the same time, interventional pain physicians manage a large population of patients earlier in the disease process — but historically without structural procedural solutions. Our strategy brings both groups toward the middle. We are moving spine surgeons upstream — away from purely reconstructive surgery — and enabling interventional pain physicians to move beyond symptom modulation toward structural correction. That middle represents a significant expansion of the Total Addressable Market (TAM). By treating patients earlier with motion-preserving, anatomy-respecting procedures in the ASC setting: More patients become procedural candidates Fear of spine surgery decreases Cost barriers decline If successful, we believe this shift can expand the spine TAM to more than 3x its current size. We are building the patented technologies, standardized training infrastructure, and outpatient execution model to lead that expansion.